CR

CreoSG Co.,Ltd.

Offers IT solutions to financial institutions and develops vaccines for HIV and coronaviruses.

040350 | KO

Overview

Corporate Details

ISIN(s):
KR7040350001
LEI:
Country:
South Korea
Address:
서울특별시 강남구 테헤란로13길 31-1 4층(역삼동, 일리빌딩), 강남구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

CreoSG Co., Ltd. operates as a diversified company with two primary business segments: IT solutions and biotechnology. The IT division specializes in developing and supplying software and next-generation systems for financial institutions, offering services that include application development, IT outsourcing, and infrastructure management. Concurrently, the company has a significant focus on the biotechnology sector, primarily conducting vaccine research and development. This division leverages a proprietary recombinant VSV (Vesicular Stomatitis Virus) vector platform technology to develop novel vaccines, with key projects targeting HIV/AIDS and various coronaviruses.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-19 00:00
Share Issue/Capital Change
증권발행결과(자율공시) (제3자배정-소액공모)
Korean 7.5 KB
2025-09-19 00:00
Share Issue/Capital Change
소액공모실적보고서
Korean 29.0 KB
2025-09-18 00:00
Major Shareholding Notification
최대주주변경을수반하는주식담보제공계약해제ㆍ취소등
Korean 19.8 KB
2025-09-11 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(유상증자결정)
Korean 51.0 KB
2025-09-11 00:00
Share Issue/Capital Change
소액공모공시서류(지분증권)
Korean 2.2 MB
2025-09-10 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(유상증자결정)
Korean 60.5 KB
2025-09-08 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 163.4 KB
2025-09-03 00:00
Share Issue/Capital Change
주요사항보고서(유상증자결정)
Korean 39.7 KB
2025-09-01 00:00
Capital/Financing Update
전환사채(해외전환사채포함)발행후만기전사채취득 (제22회차)
Korean 9.3 KB
2025-08-29 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(유상증자결정)
Korean 44.9 KB
2025-08-20 00:00
Regulatory News Service
불성실공시법인지정 (공시불이행)
Korean 6.1 KB
2025-08-14 00:00
Audit Report / Information
반기검토(감사)의견부적정등사실확인(자본잠식률100분의50이상또는자기자본10억원미만포함)
Korean 12.2 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.9 MB
2025-07-30 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(유상증자결정)
Korean 44.6 KB
2025-07-29 00:00
Regulatory News Service
불성실공시법인지정예고 (공시불이행)
Korean 5.0 KB

Automate Your Workflow. Get a real-time feed of all CreoSG Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CreoSG Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CreoSG Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Resolute Holdings Management, Inc. Logo
Asset management firm acquiring and operationally enhancing companies for long-term growth.
United States of America
RHLD
Develops RNA aptamer therapeutics for ophthalmology, pain, fibrosis, and other unmet medical needs.
Japan
4591
Rise Consulting Group, Inc. Logo
Execution-focused consulting for strategy and digital transformation, specializing in JP-CN markets.
Japan
9168
ROQUEFORT THERAPEUTICS PLC Logo
Developing first-in-class, pre-clinical medicines for hard-to-treat cancers.
United Kingdom
ROQ
ROSS GROUP PLC Logo
A holding company in liquidation, formerly providing supply chain management & technology solutions.
United Kingdom
RGP
ROXX, Inc. Logo
HR tech platform connecting non-desk job seekers with full-time roles using AI and vetting tools.
Japan
241A
SAFTEC CO.,LTD. Logo
Rents and sells safety equipment for construction, from basic supplies to AI/IoT solutions.
Japan
7464
Salarius Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted protein therapies for cancer and viral diseases.
United States of America
SLRX
Saniona Logo
Develops ion channel medicines for rare neurological diseases and epilepsy.
Denmark
SANION
Santech Holdings Ltd Logo
A technology company developing innovative consumer and enterprise technology businesses.
United States of America
STEC

Talk to a Data Expert

Have a question? We'll get back to you promptly.